Table I.
Marker | Tumour | (intensity/% of area; localization) |
---|---|---|
EGFR | Primary | – |
Mesenteric | – | |
Colonic: sarcomatoid field | – | |
Colonic: thecomatous field | +/75; C | |
WT1 | Primary | +/10; C |
Mesentery | +/5; C | |
Colonic: sarcomatoid field | ++/30; +++/20; C | |
Colonic: thecomatous field | – | |
Bcl2 | Primary | +/1; C |
Mesentery | – | |
Colonic: sarcomatoid field | ++/20; C | |
Colonic: thecomatous field | – | |
ERβ | Primary | +/70; C, N |
Mesentery | +/35; ++/50; C, N | |
Colonic: sarcomatoid field | ++/70; C, N | |
Colonic: thecomatous field | ++/100; C, N | |
Fascin | Primary | +++/90; C |
Mesentery | ++/45; +++/40; C | |
Colonic: sarcomatoid field | +/10; ++/50; +++/30; C | |
Colonic: thecomatous field | +/50; C |
C – cytoplasmic staining, N – nuclear staining. Staining intensity was scored as follows: negative –, weak +, moderate ++, and strong +++